Bank of Jackson Hole Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-169
Closed -$23.6K 165
2026
Q1
$23.6K Buy
169
+129
+323% +$18.1K 0.01% 324
2025
Q4
$4.91K Buy
+40
New +$4.86K ﹤0.01% 457
2025
Q3
Sell
-15
Closed -$1.66K 454
2025
Q2
$1.66K Hold
15
﹤0.01% 430
2025
Q1
$1.72K Hold
15
﹤0.01% 433
2024
Q4
$1.39K Buy
+15
New +$1.35K ﹤0.01% 489

Other funds holding GILD

Bank of Jackson Hole Trust's GILD Position: Q2 2026 in Review

Bank of Jackson Hole Trust sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 169 shares — an estimated $23.6K sold.

Bank of Jackson Hole Trust first reported a position in GILD in Q4 2024 and held it in 5 quarters. The position peaked at $23.6K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bank of Jackson Hole Trust reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Bank of Jackson Hole Trust sold 169 Gilead Sciences shares in Q2 2026, an estimated $23.6K.
  • Bank of Jackson Hole Trust first reported a position in Gilead Sciences in Q4 2024 and held it in 5 quarters.
  • Bank of Jackson Hole Trust's Gilead Sciences position peaked at $23.6K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bank of Jackson Hole Trust's 13F filing for Q2 2026.